FIELD: medicine, veterinary science.
SUBSTANCE: the suggested preparation consists of formalin-inactivated suspension of B.mallei deep culture sorbed upon aluminum hydroxide. The content of components, 1 cu. cm of the preparation: inactivated cell B.mallei 0.1-10 billion, aluminum ions up to 2.5 mg, formaldehyde - not more than 0.005%. Vaccination should be performed once annually, stable immunity should be formed to 7-14 d.
EFFECT: increased immunogenicity.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING DRY DIAGNOSTIC POLYVALENT GLANDEROUS SERUM | 2001 |
|
RU2188035C1 |
METHOD FOR OBTAINING ERYTHROCYTIC ANTIGENIC GLANDEROUS DIAGNOSTIC KIT | 2001 |
|
RU2188036C1 |
METHOD FOR DETERMINING BURKHOLDERIA MALLEI CAPSULAR ANTIGEN IMMUNOGENICITY LEVEL | 2005 |
|
RU2293993C1 |
METHOD OF SPECIFIC PROPHYLAXIS OF MELIODOSIS | 1992 |
|
RU2065308C1 |
POLYVALENT CORPUSCULAR ANTIGEN FOR PRODUCTION OF MEDICAL AND PREVENTIVE BIOLOGICAL PRODUCTS FOR BRUCELLOSIS | 2006 |
|
RU2330681C1 |
METHOD OF TREATING EXPERIMENTAL MALLEUS | 2012 |
|
RU2490013C1 |
NEW MULTIVALENT VACCINE AGAINST HUMAN LEPTOSPIROSIS AND A METHOD FOR ITS PRODUCTION | 2021 |
|
RU2753972C1 |
ANTIGENIC COMPOSITION OF PLAGUE CHEMICAL VACCINE | 2001 |
|
RU2190424C1 |
METHOD FOR PREPARING ERYTHROCYTIC DIAGNOSTIC ANTIGEN FOR DETECTING ACTINOBACILLUS MALLEI AND MELIOIDOSIS ANTIGEN ANTIBODIES | 2013 |
|
RU2540902C1 |
POLYVALENT VACCINE AGAINST HUMAN LEPTOSPIROSIS AND METHOD OF ITS PREPARING | 1998 |
|
RU2184775C2 |
Authors
Dates
2005-10-27—Published
2004-09-08—Filed